MassBio panelists discuss clinical trial diversity, ‘potential for health equity’


Experts at a MassBio conference said that the biotech and healthcare industries still have work to do in closing inequity gaps by ensuring racially diverse participation in clinical trials.

Previous Form D Friday: Startup with 'a fresh look at college sports' raises capital
Next Cajun-style restaurant set to bring New Orleans to North Baltimore